The cyclic cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes (cGAS)-stimulator of interferon genes (STING) pathway is important in innate immune response and has been linked to cardiovascular inflammation, remodeling, and degeneration.
Cardiovascular diseases (CVDs) are a leading cause of death worldwide. Inflammation is a key factor in the development and progression of CVDs. The cGAS-STING pathway is a newly discovered signaling pathway that plays a critical role in inflammation.
New research has shown that the cGAS-STING pathway is activated in a variety of CVDs, including myocardial infarction, heart failure, and myocarditis. This activation leads to the production of inflammatory cytokines, which can damage the heart and contribute to the progression of CVD.
Researchers are now investigating the potential of targeting the cGAS-STING pathway for the treatment of CVDs. This could lead to the development of new therapies that could improve the lives of millions of people.
Key points to remember:
- The cGAS-STING route is a recently identified signaling system that is important in inflammation.
- In a number of CVDs, the cGAS-STING pathway is activated.
- Targeting the cGAS-STING pathway may lead to novel CVD treatments.